Okan Gultekin
Solna, AB 17165, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Unmasking the common enemy: drug resistance mechanisms across three different EGFR inhibitor generations are associated with co-targetable alterations in extracellular matrix signaling.
Journal: Cell communication and signaling : CCS
Published: October 30, 2025
Systemic and tumor-specific inflammatory markers VCAM-1 and ICAM-1 as indicators of extent of surgery and oncologic outcome in advanced ovarian cancer.
Journal: Translational oncology
Published: March 28, 2025
Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian Cancer.
Journal: Cancer immunology research
Published: September 01, 2024
The extracellular matrix - immune microenvironment crosstalk in cancer therapy: Challenges and opportunities.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: April 06, 2023
MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness.
Journal: Molecular oncology
Published: August 09, 2022
Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance.
Journal: Seminars in cancer biology
Published: December 23, 2021
FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation.
Journal: NPJ precision oncology
Published: April 21, 2021
Mesothelin-Specific CAR T Cells Target Ovarian Cancer.
Journal: Cancer research
Published: August 20, 2020
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.
Journal: Nature communications
Published: June 03, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026